Get started
Author

Jeremiah Fairbanks

Institution: Allina Health
ORCID: 0000-0001-6882-7010
Observed ORCID: 0000-0001-6882-7010
OpenAlex ID: A5073336746
Evidence-Based Pharmacotherapies for Alcohol Use Disorder
2020 · Jeremiah Fairbanks, Audrey Umbreit, et al. · Mayo Clinic Proceedings · 75
PDF
Substance use disorders: diagnosis and management for hospitalists
2020 · Ahmed K. Pasha, Arnab Chowdhury, et al. · Journal of Community Hospital Internal Medicine Perspectives · 40
Is long-acting naltrexone an effective medication for reducing alcohol consumption in adult patients with alcohol use disorder?
2020 · Jeremiah Fairbanks, Rosean Bishop · Evidence-Based Practice · 2
In patients undergoing ambulatory, medically supervised alcohol withdrawal, is gabapentin or a benzodiazepine more effective in alleviating symptoms of withdrawal and preventing worsening symptoms?
2020 · Jeremiah Fairbanks, Grant Bludorn, et al. · Evidence-Based Practice · 1
Program personnel perspectives and outcomes of the Minnesota Addiction Recovery Initiative (MARI) Safe Station program: A fire station-based substance use deflection program
2026 · Nathan W. Koranda, Jeremiah Fairbanks, et al. · Journal of Substance Use and Addiction Treatment
In cocaine-dependent adults, is dexamphetamine effective for achieving cocaine cessation?
2020 · Jeremiah Fairbanks, Beth Brinkman, et al. · Evidence-Based Practice
In reply—Pharmacotherapies for Alcohol Use Disorder: Over Both Sides of the Atlantic Ocean
2020 · Jeremiah Fairbanks, Audrey Umbreit, et al. · Mayo Clinic Proceedings
In patients who smoke cigarettes, is varenicline with bupropion combination therapy more effective than varenicline monotherapy for smoking cessation?
2020 · Jeremiah Fairbanks, Ryan Brower, et al. · Evidence-Based Practice
Works count: 8
Citation count: 118
H-index: 2
I10-index: 2
Year
Topic
Type